AMMJ · As filed with the SEC

American Cannabis Company income statement, by quarter

The statement as American Cannabis Company presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) · USD, except per-share amounts

USD, except per-share amounts	Q2 2024 3 months ended Jun 30, 2024	Q1 2024 3 months ended Mar 31, 2024	Q4 2023^† 3 months ended Dec 31, 2023	Q3 2023^† 3 months ended Sep 30, 2023	Q2 2023^† 3 months ended Jun 30, 2023	Q1 2023 3 months ended Mar 31, 2023	Q4 2022^† 3 months ended Dec 31, 2022	Q3 2022^† 3 months ended Sep 30, 2022
Revenue
Consulting Services	—	—	—	—	—	160,815	—	66,824
Product & Equipment	—	—	—	—	—	363,549	—	1,866,725
Cannabis Products	—	—	—	—	—	188,021	—	190,067
Consulting Services	21,629	8,329	58,061^†	168,528	307,685	—	166,965^†	66,824^†
Product & Equipment	86,788	17,601	38,191^†	218,242	374,209	—	10,998,819^†	1,866,724^†
Cannabis Products	323,461	229,891	184,929^†	213,120	170,835	—	155,015^†	190,067^†
Total Revenues	431,878	255,720	281,181^†	599,890	852,730	712,385	11,320,799^†	2,123,616
Cost of Revenue
Cost of Consulting Services	—	—	—	—	—	45,000	—	19,500
Cost of Products and Equipment	—	—	—	—	—	217,567	—	1,664,235
Cost of Cannabis Products	—	—	—	—	—	173,309	—	180,701
Cost of Consulting Services	—	—	0^†	12,000	58,085	—	(6,176)^†	19,500^†
Cost of Products and Equipment	72,130	17,262	29,457^†	187,818	290,079	—	9,602,216^†	1,664,235^†
Cost of Cannabis Products	662,852	132,764	131,473^†	151,335	138,179	—	254,908^†	180,701^†
Total Cost of Revenues	—	—	—	351,154	—	—	—	—
Total Cost of Revenues	734,982	150,026	—	—	486,343	435,876	9,850,948^†	1,864,436
Gross Profit	(303,104)	105,694	9,220,251^†	248,717	366,386	276,509	1,469,851^†	259,180
Operating Expenses
Selling, General and Administrative Expense	249,309	232,134	242,289^†	326,429	437,996	643,604	882,132^†	617,270
Selling, General and Administrative Expense	4,334	2,350	(14,589)^†	51,675	52,849	64,535	60,406^†	64,017
Stock-Based Compensation Expense	—	—	—	0^†	7,935	9,086	—	56,170
Total Operating Expenses	253,643	234,483	3,298,926^†	378,104	498,779	717,225	904,839^†	737,458
Loss from Operations	(556,747)	(128,789)	(3,178,675)^†	(129,367)	(132,393)	(440,716)	565,012^†	(478,277)
Other Income (Expenses)
Net Interest Income	—	—	—	(28,690)	(32,728)	(31,634)	—	77,381
Interest (expense)	—	(7,479)	—	—	—	—	—	—
Interest Expense	(82,504)	—	—	—	—	—	—	—
Gain on fair market value of derivatives	3,080	—	—	—	—	—	—	—
Other Income	(1)	3,718	117,129^†	900	176,966	9,350	2,534^†	3,247
Total Other Income (Expenses)	(79,425)	(3,761)	96,574^†	(27,791)	144,237	(22,284)	(107,576)^†	80,627
Net Loss	—	—	—	—	—	(463,000)	—	—
Net Loss	—	—	—	11,844	11,844	—	59,786^†	0^†
Profit or Loss	—	(132,551)	—	—	—	—	—	—
Loss Before Income Taxes	(636,172)	—	—	—	—	—	—	—
NET LOSS	—	—	—	—	—	(463,000)	—	(397,650)
Basic and diluted weighted average common shares outstanding	—	—	—	85,727,938	85,727,938	—	—	—
NET (Loss) Income	(636,172)	(132,551)	—	(157,158)	66,019^†	—	—	(397,650)
Earnings Per Share (Basic)	0.00	0.00	—	0.00	0.00	0.00	—	0.00
Basic and diluted weighted average common shares outstanding	—	—	—	—	—	85,727,938	—	85,727,938
Earnings Per Share (Diluted)	0.00	—	—	—	—	—	—	—
Weighted Average Shares Outstanding	185,800,915	85,727,938	—	—	—	—	—	—
Weighted Average Shares Outstanding, Diluted	185,800,915	85,727,938	—	—	—	—	—	—

† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.